mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |